Outcome prediction by extranodal involvement, IPI, and R-IPI in the PET/CT and rituximab era: A Danish-Canadian study of 443 patients with diffuse-large B-cell lymphoma

Tarec Christoffer El-Galaly, Diego Villa, Musa Alzahrani, Jakob Werner Hansen, Laurie H Sehn, Don Wilson, Peter de Nully Brown, Annika Loft, Victor Iyer, Hans Erik Johnsen, Kerry J Savage, Joseph M Connors, Martin Hutchings

Research output: Contribution to journalJournal articleResearchpeer-review

30 Citations (Scopus)
Original languageEnglish
JournalAmerican Journal of Hematology
Volume90
Issue number11
Pages (from-to)1041-1046
Number of pages6
ISSN0361-8609
DOIs
Publication statusPublished - 2015

Fingerprint Dive into the research topics of 'Outcome prediction by extranodal involvement, IPI, and R-IPI in the PET/CT and rituximab era: A Danish-Canadian study of 443 patients with diffuse-large B-cell lymphoma'. Together they form a unique fingerprint.

  • Cite this

    El-Galaly, T. C., Villa, D., Alzahrani, M., Hansen, J. W., Sehn, L. H., Wilson, D., de Nully Brown, P., Loft, A., Iyer, V., Johnsen, H. E., Savage, K. J., Connors, J. M., & Hutchings, M. (2015). Outcome prediction by extranodal involvement, IPI, and R-IPI in the PET/CT and rituximab era: A Danish-Canadian study of 443 patients with diffuse-large B-cell lymphoma. American Journal of Hematology, 90(11), 1041-1046. https://doi.org/10.1002/ajh.24169